CorMedix Inc.
CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care
ZYNRELEF®, APONVIE®, CINVANTI® and SUSTOL® — to CorMedix’s hospital- and acute-care-focused commercial platform